Navigation Links
OncologySTAT Advisors Name Year's Top Developments in Cancer Treatment and Research
Date:9/9/2008

OncologySTAT Marks One-Year Anniversary with Expert Physician Commentaries

on Recent Cancer Research and Practice Developments Expert Physician Panel Selects Biomarker-Directed, Individualized Cancer

Treatment as Year's Most Influential Oncology Development

NEW YORK, Sept. 9 /PRNewswire/ -- OncologySTAT (http://www.OncologySTAT.com), a free web site featuring high-quality, scientifically based research and cancer care information for oncologists and other healthcare professionals, today celebrated its one-year anniversary by releasing a list of the most influential oncology developments of the past year chosen by an expert physician panel. Two overriding themes of this unique online editorial feature (http://www.oncologystat.com/home/Editors_Corner/1_Year_Anniversary.html) are biomarker-directed treatment decisions and the growing clinical role of personalized medicine.

OncologySTAT's expert panel includes 12 of the most influential names in hematology and oncology, including two past-presidents of the American Society of Clinical Oncology (ASCO). Based on their expertise and experience, this distinguished group identified the developments with the greatest potential for shaping the future direction of oncology.

"The story of biomarkers reverberates across various tumor types and offers a new paradigm for cancer treatment," says Lee Schwartzberg, M.D., F.A.C.P., OncologySTAT's Editor-in-Chief. "Cancer care professionals will benefit from a review of this and other top cancer developments generated collaboratively by OncologySTAT's panel of the world's leading oncologists and made accessible through links to original research and expert commentary on OncologySTAT."

The advisors' top story choices reflect a trend toward tumor subtype analysis and treatments based on both traditional markers and new biomarkers. "Where oncologists used to prescribe chemotherapy for all cancer patients, they now hunt for biomarkers to ensure they can match the cancer patient with the most appropriate, cost-effective treatments," says Axel Grothey, M.D., OncologySTAT's Associate Editor.

"The path toward such types of cancer treatment won't be easy. Oncologists who pursue personalized medicine face challenges related to logistics, handling of tumor specimens, and testing of individualized treatments in clinical trials," notes Dr. Grothey. "Still, OncologySTAT's expert panel expects genetic mutations and biomarkers to have a growing role in treating more common cancer types such as lung cancer. Eventually, oncologists will pay less attention to a patient's cancer type than to genetic changes and other types of tumor markers."

Leading Professional Online Resource

Oncologists turn to OncologySTAT to find scientific evidence on new and emerging developments such as biomarker-directed treatment. The top stories of the year selected by OncologySTAT's expert advisors illustrate the high level of scientific research within the oncology community, as well as the importance of OncologySTAT as a convenient, free online resource for the best available oncology journals and articles.

OncologySTAT has secured more than 16,000 registrants since its launch in September 2007. Backed by the support of major healthcare and pharmaceutical companies, the site has successfully captured more than 30% of US oncologists and hematologists as they actively seek clinical oncology information online. As physicians and other healthcare professionals involved in cancer care now comprise 80% of site users, OncologySTAT has emerged as one of the most trusted and trafficked professional websites in oncology.

"OncologySTAT is proud to promote state-of-the-art cancer care by providing oncology professionals with instant online access to the highest-quality news, expert opinion and clinical information available," said Monique Fayad, Senior Vice President at Elsevier and Publisher, OncologySTAT. "Only by having the latest scientific evidence at their fingertips can oncologists and other cancer care professionals deliver the quality care that cancer patients and their families need and expect."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Tom Reller

Director, Corporate Relations

212.462.1912

T.Reller@Elsevier.com


'/>"/>
SOURCE OncologySTAT
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MEDdevice Acquisition Co., LLC Announces Board Members and Advisors
2. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
3. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
4. Physicians Expect to Shift More Time to Online Professional Resources in the Coming Years
5. Second Quarter Health Care M&A Strongest In Years According To New Report From Irving Levin Associates, Inc.
6. CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years
7. Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the Worlds Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound.
8. Graphene-based gadgets may be just years away
9. Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations
10. Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years
11. Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Jan. 23, 2017  Alkahest Inc. ("Alkahest"), a ... neurodegenerative diseases and other age-related conditions, announced today ... as Chief Medical Officer. In this role, Dr. ... activities at Alkahest and serve on the Executive ... served as Executive Director at Dynavax, where he ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... endeavors to bring to market a pioneering medical device for the treatment of ... an engagement contract with Emergo, a global regulatory consultancy that helps companies like ...
(Date:1/20/2017)... ... January 20, 2017 , ... The two newest companies ... options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, launched ... space at 3624 Market Street. , Vironika is developing a treatment for a ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
Breaking Biology Technology:
(Date:12/15/2016)... HILLS, Mich. , Dec. 15, 2016  There ... unlocking car doors or starting the engine. Continental will ... in Las Vegas . Through the ... (Passive Start and Entry) and biometric elements, the international ... field of vehicle personalization and authentication. "The ...
(Date:12/8/2016)... 8, 2016 Market Research Future published a half cooked ... Mobile Biometric Security and Service Market is expected to grow over ... Market Highlights: ... Mobile Biometric Security and Service ... increasing need of authentication and security from unwanted cyber threats. The ...
(Date:12/7/2016)... AVIV, Israel , December 7, 2016 ... with the expansion of its patent portfolio, which grew to over 40 ... , , ... by its recently filed patent entitled " System, Device, and ... covers technology that enables device makers to forego costly hardware components needed ...
Breaking Biology News(10 mins):